Pulmonx EPS - Earnings per Share 2019-2025 | LUNG
Pulmonx eps - earnings per share from 2019 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Pulmonx Annual EPS | |
|---|---|
| 2024 | $-1.44 |
| 2023 | $-1.60 |
| 2022 | $-1.59 |
| 2021 | $-1.35 |
| 2020 | $-3.16 |
| 2019 | $-11.66 |
| 2018 | $-11.03 |
| Pulmonx Quarterly EPS | |
|---|---|
| 2025-09-30 | $-0.34 |
| 2025-06-30 | $-0.38 |
| 2025-03-31 | $-0.36 |
| 2024-12-31 | $-0.33 |
| 2024-09-30 | $-0.36 |
| 2024-06-30 | $-0.39 |
| 2024-03-31 | $-0.36 |
| 2023-12-31 | $-0.36 |
| 2023-09-30 | $-0.39 |
| 2023-06-30 | $-0.43 |
| 2023-03-31 | $-0.42 |
| 2022-12-31 | $-0.38 |
| 2022-09-30 | $-0.38 |
| 2022-06-30 | $-0.40 |
| 2022-03-31 | $-0.43 |
| 2021-12-31 | $-0.36 |
| 2021-09-30 | $-0.28 |
| 2021-06-30 | $-0.36 |
| 2021-03-31 | $-0.35 |
| 2020-12-31 | $8.12 |
| 2020-09-30 | $-1.37 |
| 2020-06-30 | $-6.15 |
| 2020-03-31 | $-3.76 |
| 2019-12-31 | $0.00 |
| 2019-09-30 | $-2.41 |
| 2018-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.077B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.120B | 41.77 |
| Tempus AI (TEM) | United States | $11.621B | 0.00 |
| Doximity (DOCS) | United States | $7.503B | 30.89 |
| Hims & Hers Health (HIMS) | United States | $6.577B | 53.50 |
| IRhythm Holdings (IRTC) | United States | $5.273B | 0.00 |
| Hinge Health (HNGE) | United States | $3.268B | 0.00 |
| Privia Health (PRVA) | United States | $2.903B | 181.54 |
| 10x Genomics (TXG) | United States | $2.870B | 0.00 |
| Heartflow (HTFL) | United States | $2.857B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.795B | 46.25 |
| Omnicell (OMCL) | United States | $2.265B | 46.31 |
| Azenta (AZTA) | United States | $1.857B | 76.17 |
| Enovis (ENOV) | United States | $1.354B | 7.11 |
| Clover Health Investments (CLOV) | United States | $1.354B | 0.00 |
| Schrodinger (SDGR) | United States | $1.210B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.117B | 0.00 |
| Phreesia (PHR) | United States | $0.942B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.861B | 0.00 |
| Talkspace (TALK) | United States | $0.633B | 127.33 |
| Standard BioTools (LAB) | United States | $0.631B | 0.00 |
| Claritev (CTEV) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.424B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.366B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.90 |
| Senseonics Holdings (SENS) | United States | $0.295B | 0.00 |
| CapsoVision (CV) | United States | $0.289B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.264B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.183B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| CareCloud (CCLD) | United States | $0.124B | 6.81 |
| Outset Medical (OM) | United States | $0.094B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.062B | 0.00 |
| 111 (YI) | China | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.035B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.019B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |